Skip to main content
. 2016 Jan 14;11(1):e0146767. doi: 10.1371/journal.pone.0146767

Table 1. Hemodynamic and functional characteristics.

Conductance and echocardiographic results presented as median (range) as the data is not normally distributed. Pes: end-systolic pressure, Ped: end-diastolic pressure. Sham (n = 3), PAB (n = 5), and PAB+ERB (n = 5). The groups were compared using Kruskal-Wallis multiple comparisons. Post hoc test showed:

LV Sham (Range) PAB (Range) PAB+ERB (Range)
Conductance
dP/dt max (mmHg/s) 1536 (1258 to 3307) 1655 (1229 to 2460) 1385 (1152 to 2429)
Tau 24 (12 to 35) 16 (13 to 21) 21 (17 to 30)
Pes (mmHg) 45 (44 to 77) 45 (38 to 67) 33 (23 to 76)
Ped (mmHg) 13 (7 to 15) 7 (0 to 11) 4 (1 to 25)
Echocardiography
E’ (cm/s) 9.2 (7.2 to 11.9) 4.1 (1.6 to5.9) 5.6 (2.7 to 5.3)
S’ (cm/s) 4.8 (4.5 to 7.9) 3.2 (1.1 to 3.7) 4.5 (3.9 to 5.3)
MPI 0.45 (0.41 to 0.61) 0.43 (0.39 to 0.53) 0.35 (0.27 to 0.39)
FS (%) 32 (21 to 39) 39.5 (26 to 43) 36 (31 to 48)
RV  
Conductance
dP/dt max (mmHg/s) 571 (484 to 776) 525 (435 to 919) 871 (636 to 2593)
Tau 7 (4 to 20) 28* (27 to 32) 24 (19 to 28)
Pes (mmHg) 18 (13 to 18) 24 (21 to 34) 26 (21 to 39)
Ped (mmHg) 3 (1 to 6) 10 (4 to 12) 6 (5 to 11)
Echocardiography
E’ (cm/s) 12.7 (9.5 to 23.1) 4 (1.8 to 8) 9.8 (2.5 to 13.8)
S’ (cm/s) 9.7 (5.5 to 11.2) 3.2** (2 to 3.5) 6 (1.9 to 8.4)
MPI 0.17 (0.12 to 0.47) 0.36 (0.21 to 0.57) 0.28 (0.15 to 0.49)
TAPSE (cm) 0.44 (0.31 to 0.53) 0.31 (0.23 to 0.45) 0.38 (0.29 to 0.55)

*RV Tau, the time constant of pressure decay increased with PAB compared to Sham p≤0.05, but did not change with addition of macitentan.

**RV-S’ decreased with PAB compared to Sham p≤0.05, however no significant increase with addition of macitentan.